Skip to main content
  1. Home
  2. Emerging Tech
  3. Music
  4. News

Watch this dude bang out a funky electro number on a bunch of ancient TVs

Add as a preferred source on Google

When Ei Wada comes across a pile of discarded electronic equipment, he sees not a pile of trash but instead a bunch of musical instruments.

For the last seven years, the Japanese experimental musician has been gathering together all manner of e-waste, using anything he can lay his hands on to create beautiful music – or not, depending on your taste.

Recommended Videos

At a recent festival in Ibaraki just north of Tokyo, Wada, performing with his wonderfully named Braun Tube Jazz Band, used a bunch of ancient cathode-ray tube TVs – and a bit of technical jiggery-pokery – to knock out some fancy tunes using the televisions as bongo drums.

Proving he’s not a one-instrument wonder, and showcasing his ability to create an instrument out of virtually any household appliance known to man, 29-year-old Wada then picks up an electric fan for another spacey track.

"Ei WADA" performance show in the Ibaraki-ken north area Part3

According to his website, Wada kicked off his unusual career with the creation of the Open Reel Ensemble, a group that manipulates and plays reel-to-reel audio recorders.

The group sounds pretty busy, performing live shows, creating art installations, and providing music for movies and catwalk shows.

His unique talent has even been spotted by legendary Japanese fashion designer Issey Miyake, who in recent years has used his music at multiple fashion events in Paris.

Wada’s latest project is called “Electronicos Fantasticos!”, which apparently involves building “humongous radio wave towers.”

“All these tech objects are a symbol of Japan’s economic growth, but they also get thrown away in great numbers,” Wada told Motherboard in an interview earlier this year. “It’s good to not just say ‘bye’ to things that are thrown away but to instill old things with new meaning, and celebrate their unique points.”

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more